The overexpression of IGF2BP1 was correlated with tumour size and shorter overall survival (OS) in pancreatic cancer patients, highlighting its clinical relevance as a prognostic marker [147,148]. The gene discussed is IGF2BP1; the disease is pancreatic neoplasm.